 Home > Active Ingredient News > Immunology News > ARD: The short-term dose and duration-dependent risk of cardiovascular events of glucocorticoids in patients with rheumatoid arthritis initially treated with glucocorticoids

ARD: The short-term dose and duration-dependent risk of cardiovascular events of glucocorticoids in patients with rheumatoid arthritis initially treated with glucocorticoids

 Last Update: 2021-12-27
 Source: Internet
 Author: User

Tags

solifenacin 10 mg

tylenol mg dosage

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Objective : Rheumatoid arthritis (RA) and the use of corticosteroids and cardiac vascular diseases
.

The cardiovascular safety of glucocorticoids in RA is controversial, which may be related to the dosage and duration of use

Objective : rheumatoid arthritis (RA) and the use of corticosteroids and cardiac vascular diseases

Methods : included CorEvitas (formerly known as CORRONA ) RA patients registered

Results : 19 902 patients met the criteria

Conclusion : In the previous 6 months and 1 year intervals, after the RA patients who did not use glucocorticoids started to use glucocorticoids, the daily dose ≥ 5 mg , the cumulative dose and the duration of use increased were related to the increased risk of CVE .
Daily prednisone ≤ 4 mg or less cumulative dose and shorter duration are not related to the risk of CVE .

Source:

Ocon AJ, Reed G, Pappas DA , et al .

Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Annals of the Rheumatic Diseases2021; 80: 1522-1529.

Ocon AJ, Reed G, Pappas DA , et al .
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Annals of the Rheumatic Diseases2021; 80: 1522-1529.
, et al Annals of the Rheumatic Diseases 80: Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.